Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.

Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J.

J Exp Med. 2009 Mar 16;206(3):637-53. doi: 10.1084/jem.20082109. Epub 2009 Feb 23.

2.

Fungal pathogen recognition by scavenger receptors in nematodes and mammals.

Means TK.

Virulence. 2010 Jan-Feb;1(1):37-41. doi: 10.4161/viru.1.1.10228.

3.

Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans.

Nicola AM, Albuquerque P, Martinez LR, Dal-Rosso RA, Saylor C, De Jesus M, Nosanchuk JD, Casadevall A.

Infect Immun. 2012 Sep;80(9):3065-76. doi: 10.1128/IAI.00358-12. Epub 2012 Jun 18.

4.

The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans).

Ramirez-Ortiz ZG, Means TK.

Virulence. 2012 Nov 15;3(7):635-46. doi: 10.4161/viru.22295. Epub 2012 Oct 17. Review.

5.

Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans.

Blasi E, Mucci A, Neglia R, Pezzini F, Colombari B, Radzioch D, Cossarizza A, Lugli E, Volpini G, Del Giudice G, Peppoloni S.

FEMS Immunol Med Microbiol. 2005 Apr 1;44(1):69-79.

6.

Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae.

Kasperkovitz PV, Khan NS, Tam JM, Mansour MK, Davids PJ, Vyas JM.

Infect Immun. 2011 Dec;79(12):4858-67. doi: 10.1128/IAI.05626-11. Epub 2011 Sep 26.

7.
8.

Effect of Listeria monocytogenes lipids on the immunity of mice against Candida albicans, Cryptococcus neoformans and Trichomonas vaginalis.

Jakoniuk P, Jabłońska-Strynkowska W, Musiatowicz B, Borowski J.

Arch Immunol Ther Exp (Warsz). 1980;28(3):377-87.

PMID:
6778451
9.

A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity.

Tenor JL, Aballay A.

EMBO Rep. 2008 Jan;9(1):103-9. Epub 2007 Nov 2.

10.

Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?

Casadevall A, Cassone A, Bistoni F, Cutler JE, Magliani W, Murphy JW, Polonelli L, Romani L.

Med Mycol. 1998;36 Suppl 1:95-105. Review.

PMID:
9988497
11.

CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis.

Castleman MJ, Febbraio M, Hall PR.

J Immunol. 2015 Sep 1;195(5):2294-302. doi: 10.4049/jimmunol.1500500. Epub 2015 Jul 29.

12.

TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae.

Gil ML, Gozalbo D.

Microbes Infect. 2006 Jul;8(8):2299-304. Epub 2006 Jun 5. Review.

PMID:
16782386
13.

Recognition and blocking of innate immunity cells by Candida albicans chitin.

Mora-Montes HM, Netea MG, Ferwerda G, Lenardon MD, Brown GD, Mistry AR, Kullberg BJ, O'Callaghan CA, Sheth CC, Odds FC, Brown AJ, Munro CA, Gow NA.

Infect Immun. 2011 May;79(5):1961-70. doi: 10.1128/IAI.01282-10. Epub 2011 Feb 28.

14.

Antibody immunity and invasive fungal infections.

Casadevall A.

Infect Immun. 1995 Nov;63(11):4211-8. Review. No abstract available.

15.

Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.

Capodicasa C, Chiani P, Bromuro C, De Bernardis F, Catellani M, Palma AS, Liu Y, Feizi T, Cassone A, Benvenuto E, Torosantucci A.

Plant Biotechnol J. 2011 Sep;9(7):776-87. doi: 10.1111/j.1467-7652.2010.00586.x. Epub 2011 Jan 25.

16.

The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection.

Jain C, Pastor K, Gonzalez AY, Lorenz MC, Rao RP.

Virulence. 2013 Jan 1;4(1):67-76. doi: 10.4161/viru.22700.

17.

Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Guillot L, Carroll SF, Homer R, Qureshi ST.

Infect Immun. 2008 Oct;76(10):4745-56. doi: 10.1128/IAI.00341-08. Epub 2008 Aug 4.

18.

Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses.

Pukkila-Worley R, Ausubel FM, Mylonakis E.

PLoS Pathog. 2011 Jun;7(6):e1002074. doi: 10.1371/journal.ppat.1002074. Epub 2011 Jun 23.

19.

Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.

Pietrella D, Lupo P, Perito S, Mosci P, Bistoni F, Vecchiarelli A.

FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):63-70.

20.

Candida albicans beta-glucan exposure is controlled by the fungal CEK1-mediated mitogen-activated protein kinase pathway that modulates immune responses triggered through dectin-1.

Galán-Díez M, Arana DM, Serrano-Gómez D, Kremer L, Casasnovas JM, Ortega M, Cuesta-Domínguez A, Corbí AL, Pla J, Fernández-Ruiz E.

Infect Immun. 2010 Apr;78(4):1426-36. doi: 10.1128/IAI.00989-09. Epub 2010 Jan 25.

Supplemental Content

Support Center